Thymosin beta-4 was repeatedly studied in the context of breast cancer (Zhang et al. 2017), and in line with our findings, macrophages showed intense reactivity for Thymosin beta-4 antibodies in breast cancer, while cancer cells showed a much more variable reactivity (Larsson and Holck 2007). Here, TMSB4X is linked to cancer.